IP Library Granted Patent US 10,092,676
Granted Patent B2
US 10,092,676 · App. 15/216,878 · Granted Oct 9, 2018

Biohybrid composite scaffold

Inventors: Nicholas J. Amoroso (Pittsburgh, PA); Stephen Francis Badylak (West Lafayette, IN); Yi Hong (Pittsburgh, PA); Alexander Huber (Pittsburgh, PA); Keisuke Takanari (Pittsburgh, PA); William R. Wagner (Gibsonia, PA)
Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
A61L27/18A61L27/3633A61L27/48A61L27/58A61L2400/18A61L2430/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,092,676
App. No.
15/216,878
Granted
Oct 9, 2018
Kind
B2
Abstract

A biohybrid scaffold is provided that is useful in clinical applications for abdominal wall reconstruction, pelvic floor repair, breast reconstruction, as well as other soft tissue repairs. Methods of making and using the biohybrid scaffold are provided.

Claims (29)

1. A biohybrid scaffold comprising a matrix of a biodegradable, biocompatible elastomeric polymer and an ECM-derived gel interspersed substantially evenly throughout the matrix, wherein

the ECM-derived gel composition is prepared by: (i) solubilizing decellularized tissue that has not been dialyzed by digestion with an acid protease, thereby producing a digest solution; and (ii) raising the pH of the digest solution to between 7.2 and 7.8.

2. The biohybrid scaffold of claim 1 , wherein the ECM-derived gel has a lower critical solution temperature (LCST) of less than 37° C.

3. The biohybrid scaffold of claim 2 , wherein the ECM-derived gel has an LCST of from 20° C. to less than 37° C.

4. The biohybrid scaffold of claim 1 , wherein the biodegradable, biocompatible elastomeric polymer comprises a poly(ester urethane) urea (PEUU), a poly(ether ester urethane)urea (PEEUU), a poly(ester carbonate)urethane urea (PECUU), and/or a poly(carbonate)urethane urea (PCUU).

5. The biohybrid scaffold of claim 1 , in which the biodegradable, biocompatible elastomeric polymer comprises a copolymer of polycaprolactone, 1,4-diisocyanobutane, and putrescine.

6. The biohybrid scaffold of claim 1 , further comprising one or more layers of a wet-electrospun biodegradable, biocompatible elastomeric polymer attached to the matrix of a biodegradable, biocompatible elastomeric polymer and the ECM-derived gel interspersed substantially evenly throughout the matrix, forming a composite scaffold structure.

7. The biohybrid scaffold of claim 6 , wherein the composite scaffold comprises the matrix of a biodegradable, biocompatible elastomeric polymer and an ECM-derived gel interspersed substantially evenly throughout the matrix sandwiched between two layers of the wet-electrospun biodegradable, biocompatible elastomeric polymer.

8. The biohybrid scaffold of claim 6 , wherein the wet-electrospun biodegradable, biocompatible elastomeric polymer comprises a PEUU and PBS.

9. The biohybrid scaffold of claim 6 , in which polymer fibers between the one or more layers of a wet-electrospun biodegradable, biocompatible elastomeric polymer and the matrix of a biodegradable, biocompatible elastomeric polymer and the ECM-derived gel interspersed substantially evenly throughout the matrix are interlocked or continuous between the layers.

10. A method of growing tissue in a patient comprising implanting a biohybrid scaffold comprising a matrix of a biodegradable, biocompatible elastomeric polymer and an ECM-derived gel interspersed substantially evenly throughout the matrix in a patient at a site of injury or defect in the patient, wherein

the ECM-derived gel composition is prepared by: (i) solubilizing decellularized tissue that has not been dialyzed by digestion with an acid protease, thereby producing a digest solution; and (ii) raising the pH of the digest solution to between 7.2 and 7.8.

11. The method of claim 10 , wherein the biohybrid scaffold is implanted to repair a soft-tissue injury or defect in a patient.

12. The method of claim 11 , wherein the biohybrid scaffold is implanted in the abdominal wall, the pelvic floor, or a breast of a patient, thereby repairing an injury or defect in the patient.

13. The method of claim 11 , wherein the biohybrid scaffold is implanted in an abdominal wall the patient, thereby repairing an injury or defect in the abdominal wall of the patient.

14. A biohybrid scaffold comprising:

a matrix of a biodegradable, biocompatible elastomeric polymer;

an ECM-derived gel interspersed substantially evenly throughout the matrix; and

one or more layers of a wet-electrospun biodegradable, biocompatible elastomeric polymer attached to the matrix of a biodegradable, biocompatible elastomeric polymer and the ECM-derived gel interspersed substantially evenly throughout the matrix, forming a composite scaffold structure.

15. The biohybrid scaffold of claim 14 , wherein the composite scaffold comprises the matrix of a biodegradable, biocompatible elastomeric polymer and an ECM-derived gel interspersed substantially evenly throughout the matrix sandwiched between two layers of the wet-electrospun biodegradable, biocompatible elastomeric polymer.

16. The biohybrid scaffold of claim 14 , wherein the wet-electrospun biodegradable, biocompatible elastomeric polymer comprises a PEUU and PBS.

17. The biohybrid scaffold of claim 14 , in which polymer fibers between the one or more layers of a wet-electrospun biodegradable, biocompatible elastomeric polymer and the matrix of a biodegradable, biocompatible elastomeric polymer and the ECM-derived gel interspersed substantially evenly throughout the matrix are interlocked or continuous between the layers.

18. A method of growing tissue in a patient comprising:

implanting in a patient at a site of injury or defect in the patient a biohybrid scaffold comprising:

a matrix of a biodegradable, biocompatible elastomeric polymer;

an ECM-derived gel interspersed substantially evenly throughout the matrix; and

one or more layers of a wet-electrospun biodegradable, biocompatible elastomeric polymer attached to the matrix of a biodegradable, biocompatible elastomeric polymer and the ECM-derived gel interspersed substantially evenly throughout the matrix, forming a composite scaffold structure.

19. The method of claim 18 , wherein the biohybrid scaffold is implanted to repair a soft-tissue injury or defect in a patient.

20. The method of claim 19 , wherein the biohybrid scaffold is implanted in the abdominal wall, the pelvic floor, or a breast of a patient, thereby repairing an injury or defect in the patient.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 30, 2022
From: UNIVERSITY OF PITTSBURGH
To: UNITED STATES GOVERNMENT
Reel/Frame 059543/0845 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2016
From: AMOROSO, NICHOLAS J.; BADYLAK, STEPHEN F.; HONG, YI; HUBER, ALEXANDER; TAKANARI, KEISUKE; WAGNER, WILLIAM R.
To: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 039309/0721 →
Continuity (3)
Division 13814783
Provisional Application 61374340 · Aug 17, 2010
Related Publication 20160325016A1 · Nov 10, 2016
Cited By (2)
US 12,303,533 US 12,440,444